Group One Trading’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,500
| Closed | -$17.5K | – | 8341 |
|
|
2023
Q3 | $17.5K | Hold |
12,500
| – | – | ﹤0.01% | 5980 |
|
|
2023
Q2 | $23K | Hold |
12,500
| – | – | ﹤0.01% | 5895 |
|
|
2023
Q1 | $30.4K | Sell |
12,500
-186,900
| -94% | -$278K | ﹤0.01% | 5230 |
|
|
2022
Q4 | $285K | Buy |
199,400
+17,800
| +10% | +$34.7K | ﹤0.01% | 3538 |
|
|
2022
Q3 | $405K | Buy |
+181,600
| New | +$439K | ﹤0.01% | 3441 |
|
|
2022
Q2 | – | Sell |
-1,900
| Closed | -$6K | – | 8674 |
|
|
2022
Q1 | $6K | Sell |
1,900
-55,800
| -97% | -$179K | ﹤0.01% | 7412 |
|
|
2021
Q4 | $185K | Sell |
57,700
-465,100
| -89% | -$1.59M | ﹤0.01% | 5167 |
|
|
2021
Q3 | $1.85M | Sell |
522,800
-404,400
| -44% | -$1.35M | ﹤0.01% | 2741 |
|
|
2021
Q2 | $2.94M | Sell |
927,200
-177,300
| -16% | -$558K | ﹤0.01% | 2237 |
|
|
2021
Q1 | $3.8M | Buy |
1,104,500
+492,600
| +81% | +$1.53M | 0.01% | 1801 |
|
|
2020
Q4 | $1.54M | Buy |
611,900
+580,900
| +1,874% | +$1.27M | ﹤0.01% | 2264 |
|
|
2020
Q3 | $65K | Buy |
31,000
+900
| +3% | +$2.14K | ﹤0.01% | 4472 |
|
|
2020
Q2 | $67K | Buy |
+30,100
| New | +$77.4K | ﹤0.01% | 4176 |
|
|
2018
Q3 | – | Sell |
-6,200
| Closed | -$32K | – | 5683 |
|
|
2018
Q2 | $32K | Hold |
6,200
| – | – | ﹤0.01% | 4187 |
|
|
2018
Q1 | $34K | Sell |
6,200
-9,300
| -60% | -$65.5K | ﹤0.01% | 3845 |
|
|
2017
Q4 | $126K | Sell |
15,500
-9,600
| -38% | -$91.7K | ﹤0.01% | 3220 |
|
|
2017
Q3 | $263K | Buy |
25,100
+23,100
| +1,155% | +$256K | ﹤0.01% | 2564 |
|
|
2017
Q2 | $22K | Buy |
+2,000
| New | +$18.6K | ﹤0.01% | 3919 |
|
|
2016
Q4 | – | Sell |
-9,100
| Closed | -$46K | – | 4904 |
|
|
2016
Q3 | $46K | Sell |
9,100
-7,000
| -43% | -$41.8K | ﹤0.01% | 3391 |
|
|
2016
Q2 | $96K | Sell |
16,100
-32,700
| -67% | -$181K | ﹤0.01% | 2894 |
|
|
2016
Q1 | $222K | Buy |
48,800
+16,100
| +49% | +$71.7K | ﹤0.01% | 2252 |
|
|
2015
Q4 | $147K | Buy |
+32,700
| New | +$138K | ﹤0.01% | 2726 |
|
|
2014
Q3 | – | Sell |
-19,900
| Closed | -$104K | – | 5526 |
|
|
2014
Q2 | $104K | Sell |
19,900
-1,500
| -7% | -$6.49K | ﹤0.01% | 2951 |
|
|
2014
Q1 | $89K | Buy |
21,400
+6,600
| +45% | +$22.6K | ﹤0.01% | 3179 |
|
|
2013
Q4 | $43K | Buy |
14,800
+1,300
| +10% | +$3.22K | ﹤0.01% | 3741 |
|
|
2013
Q3 | $34K | Buy |
+13,500
| New | +$32K | ﹤0.01% | 3840 |
|
Other funds holding ENZ
HFA
TCM
RC
BCM
Group One Trading's ENZ Position: Q1 2023 in Review
Group One Trading sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 27,996 shares — an estimated $41.6K sold.
Group One Trading first reported a position in ENZ in Q3 2013 and held it in 19 quarters. The position peaked at $920K in Q2 2021. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.
- Group One Trading reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 27,996 Enzo Biochem, Inc. shares in Q1 2023, an estimated $41.6K.
- Group One Trading first reported a position in Enzo Biochem, Inc. in Q3 2013 and held it in 19 quarters.
- Group One Trading's Enzo Biochem, Inc. position peaked at $920K in Q2 2021.
- 52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.